Acadia Pharmaceuticals Inc. ACAD
20.47 USD -0.12 -0.58%
At close · Nov 2
20.47 0.00 0.00%
After hours · Nov 2, 4:33 PM ET
18.39 52-week range 30.96
- YTD
- -23.36%
- 1 year
- -9.82%
- Open
- 20.71
- Prev close
- 20.59
- Mkt cap
- 3.51B
- Vol
- 1.38M
- Avg vol
- 1.87M
- EPS
- 2.23
- P/E
- 9.18
- Div yield
- 0.00%
More statistics
- Low
- 20.25
- High
- 20.76
- Forward P/E
- 22.22
- Beta
- 0.89
- Short ratio
- 3.81
- Inst. own
- 100.05%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 23.74
- 200-d avg
- 23.68
- 1y target
- 30.53
MAX chart
Chart tools
Chart is warming up
The all-time price history for ACAD has not been loaded yet. Try again in a moment.
Altman Z-Score
4.90 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A-4 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 4
- P/E 3
- P/B 2
P/E 11.5×
P/S 4.2×
P/B 3.7×
P/FCF 43.0×
EV/EBITDA 29.2×
EV/Sales 4.1×
FCF Yield 2.3%
Gross Margin 91.7%
Operating Margin 9.8%
Net Margin 36.5%
ROE 31.9%
ROIC 8.1%
ROA 25.0%
Revenue 11.9%
Operating Income -54.6%
EPS (diluted) 68.4%
Free Cash Flow -33.1%
Current Ratio 3.8×
Quick Ratio 3.7×
Debt / Equity 0.0×
Net Debt / EBITDA -0.8×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31